StephenHenryWrzesinskiMDPhD

Assistant Professor of Medicine, Albany Medical Center and Division Chief Medical Oncology/Hematology, St. Peter's Cancer Care Center

Join to view full profile

Dr. Wrzesinski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wrzesinski's full profile

Already have an account?

Office
400 Patroon Creek Blvd
Albany, NY 12206
Phone+1 518-489-0444
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2002 - 2005
SUNY Upstate Medical UniversityClass of 2002

Certifications & Licensure

NY State Medical License 2011 - 2026
CT State Medical License 2006 - 2011
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) Start of enrollment: 2014 Nov 17
Completed
Phase 3
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) Start of enrollment: 2016 Jan 15
Completed
Phase 3
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) Start of enrollment: 2019 Apr 01
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Emerging therapeutic options for periorbital and orbital cutaneous basal and squamous cell carcinomas.
Edward J Wladis, Stephen H Wrzesinski, Michael I Rothschild, Alejandro P Adam> ;Orbit. 2023 Apr 1
3 citations
Primary Intramedullary Spinal Melanoma: A Rare Disease of the Spinal Cord.
Fatima Tuz Zahra, Zainub Ajmal, Jiang Qian, Stephen Wrzesinski> ;Cureus. 2021 Jul 5
3 citations
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo
Stephen H Wrzesinski, Jan L. Fisher, Marc S. Ernstoff> ;Experimental Hematology & Oncology. 2013 Mar 9
344 citations
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park, Stephen H. Wrzesinski, Eric Stern, Michael Look, Jason M. Criscione, Ragy Ragheb, Steven M. Jay, Stacey L. Demento, Atu Agawu, Paula Licona Limon, Anthony ...> ;Nature Materials. 2012 Oct 1
11 citations
Imatinib mesylate (Gleevec) induced unilateral optic disc edema.
Crystal DeLuca, Nancy Shenouda-Awad, Charles Haskes, Stephen Wrzesinski> ;Optometry and Vision Science. 2012 Oct 1
5 citations
Radiotherapy plus chemotherapy in muscle-invasive bladder cancer.
Atkins, C. D., Wrzesinski, S. H.> ;The New England journal of medicine. 2012 Jul 27
28 citations
Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.
Guangzhi Zhang, Min Chen, Don Graham, Benchamas Subsin, Chelsea McDougall, Suzanna Gilady, Mark Kneteman, Lok Man J. Law, Mark G. Swain, Michael Trauner, Stephen H. Wr...> ;Journal of Hepatology. 2011 Oct 1
25 citations
Systemic Therapy in Hepatocellular Carcinoma
Stephen H. Wrzesinski, Tamar H. Taddei, Mario Strazzabosco> ;Clinics in Liver Disease. 2011 May 1
695 citations
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell, Shomyseh Sanjabi, Stephen H. Wrzesinski, Paula Licona-Limón> ;Nature Reviews. Immunology. 2010 Jul 9
37 citations
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy.
Erin R. Steenblock, Stephen H. Wrzesinski, Richard A. Flavell, Tarek M. Fahmy> ;Expert Opinion on Biological Therapy. 2009 Apr 3
44 citations
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes
Peter M. Rabinovich, Marina E. Komarovskaya, Stephen H. Wrzesinski, Jonathan Alderman, Tulin Budak-Alpdogan, Alexander Karpikov, Hongfen Guo, Richard A. Flavell, Nai-K...> ;Human Gene Therapy. 2008 Oct 15
332 citations
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
Stephen H. Wrzesinski, Yisong Y. Wan, Richard A. Flavell> ;Clinical Cancer Research. 2007 Sep 15
11 citations
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
Stephen H. Wrzesinski, Meghan L. McGurk, Constance T. Donovan, T. Ferencz, Muhammad Wasif Saif> ;Anti-Cancer Drugs. 2007 Jul 1
34 citations
Proinflammatory Cytokine Gene Induction by Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Tax in Primary Human Glial Cells
Prabal Banerjee, Rosemary Rochford, Jack P. Antel, G. Canute, Stephen Wrzesinski, Michelle Sieburg, Gerold Feuer> ;Journal of Virology. 2007 Feb 15
2 citations
Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomas.
Stephen H. Wrzesinski, Konstantin H. Dragnev, Lorna K. Mayo, Brent T. Harris, Jonathan D. Marotti> ;Journal of Neuro-Oncology. 2006 Feb 1
26 citations
Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro
Adam Tripp, Yingxian Liu, Michelle Sieburg, JoAnne Montalbano, Stephen Wrzesinski, Gerold Feuer> ;Journal of Virology. 2003 Nov 15
36 citations
Multigene lentiviral vectors based on differential splicing and translational control.
Yonghong Zhu, Gerold Feuer, Shannon L. Day, Stephen Wrzesinski, Vicente Planelles> ;Molecular Therapy. 2001 Oct 1
19 citations
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors.
Stephen Wrzesinski, Rosanne Seguin, Yingxian Liu, Shelley Domville, Vicente Planelles, Paul T. Massa, Edward D. Barker, Jack P. Antel, Gerold Feuer> ;AIDS Research and Human Retroviruses. 2000 Nov 1
Join now to see all

Press Mentions

Preliminary Research Involving Members of the US Oncology Network Finds Cancer Drug May Benefit Advanced COVID-19 PatientsJune 5th, 2020
Study Looks at Cancer Drug to Treat COVID-19June 5th, 2020
Local Doctors and Patients Part of a Promising Drug Study on a New Covid-19 TreatmentJune 5th, 2020